The report of the independent Life Sciences Commission, initiated earlier this year by the Greater Birmingham & Solihull Local Enterprise Partnership (GBSLEP), has been published. The Commission has looked at how Greater Birmingham can draw on its particular strengths to grow the life sciences sector for the benefit of patients and the economy. The Commission has highlighted Greater Birmingham’s potential to become a world-leading location for the rapid assessment of new drugs, diagnostics and devices. This includes a leading role in developing new models for accelerated clinical trials, which are providing patients with blood cancers with earlier access to new drugs, at no cost to the NHS. The Commission has identified a number of areas where local partners, in conjunction with the Government and industry, need to work together to unlock Greater Birmingham’s potential and also recommends investment in patient data systems, education & training, and support for small businesses looking to enter the life science and healthcare markets.